Conference News | tctmd.com

News Conference News AHA 2021

Empagliflozin Retains Benefits in ‘True’ HFpEF Patients

November 17, 2021

News Conference News AHA 2021

Aspirin Fails to Prevent Onset of Dementia in Diabetic Patients: ASCEND

By Michael O'Riordan

November 17, 2021

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

November 16, 2021

News Conference News AHA 2021

Canagliflozin Improves Quality of Life in HF Patients

By Michael O'Riordan

November 16, 2021

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

By Shelley Wood

November 15, 2021

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

November 15, 2021

News Conference News AHA 2021

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

By Yael L. Maxwell

November 15, 2021

News Conference News

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

By L.A. McKeown

November 15, 2021

News Conference News AHA 2021

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

By Michael O'Riordan

November 15, 2021

News Conference News AHA 2021

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE

By Shelley Wood

November 14, 2021

Subscribe to Conference News

Country